- Home
- NMRA vs OTLY Comparison
NMRA vs OTLY Comparison
Compare NMRA & OTLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMRA
- OTLY
- Stock Information
- Founded
- NMRA 2019
- OTLY 1994
- Country
- NMRA United States
- OTLY Sweden
- Employees
- NMRA N/A
- OTLY N/A
- Industry
- NMRA
- OTLY Packaged Foods
- Sector
- NMRA
- OTLY Consumer Staples
- Exchange
- NMRA Nasdaq
- OTLY Nasdaq
- Market Cap
- NMRA 287.6M
- OTLY 267.9M
- IPO Year
- NMRA 2023
- OTLY 2021
- Fundamental
- Price
- NMRA $0.65
- OTLY $8.62
- Analyst Decision
- NMRA Buy
- OTLY Buy
- Analyst Count
- NMRA 8
- OTLY 4
- Target Price
- NMRA $9.29
- OTLY $19.75
- AVG Volume (30 Days)
- NMRA 1.2M
- OTLY 122.1K
- Earning Date
- NMRA 05-06-2025
- OTLY 04-30-2025
- Dividend Yield
- NMRA N/A
- OTLY N/A
- EPS Growth
- NMRA N/A
- OTLY N/A
- EPS
- NMRA N/A
- OTLY N/A
- Revenue
- NMRA N/A
- OTLY $823,666,000.00
- Revenue This Year
- NMRA N/A
- OTLY $3.92
- Revenue Next Year
- NMRA N/A
- OTLY $6.14
- P/E Ratio
- NMRA N/A
- OTLY N/A
- Revenue Growth
- NMRA N/A
- OTLY 5.15
- 52 Week Low
- NMRA $0.62
- OTLY $6.00
- 52 Week High
- NMRA $17.19
- OTLY $26.80
- Technical
- Relative Strength Index (RSI)
- NMRA 22.34
- OTLY 40.83
- Support Level
- NMRA $0.64
- OTLY $8.59
- Resistance Level
- NMRA $0.83
- OTLY $9.47
- Average True Range (ATR)
- NMRA 0.09
- OTLY 0.48
- MACD
- NMRA 0.02
- OTLY -0.07
- Stochastic Oscillator
- NMRA 6.68
- OTLY 16.36
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.
About OTLY Oatly Group AB
Oatly Group AB is engaged in the food and drinks industry. Some of its products include Oat Drink, Chilled Oat Drink, Oatgurt, Creamy Oat, and Icecreams, among others. It caters to Sweden, Germany, the United Kingdom, Netherlands, North America, Finland, and Other markets. The company generates revenue from the EMEA, Americas, and Asia regions, with the majority of revenue generated from the EMEA region.